Essity AB Series B(0RQD)
SEK --+0.00%
Reward48Moderate
Risk17Low
📊50%Data
3.5% dividend yield · Revenue down 5% YoY
0RQD
+0.0 · +0.00%
SEK · LSE
Essity AB Series B |
Earnings Deterioration
Market Cap:183.28Bn
ℹ️
Reward Rating
48
Moderate
Bottom 25% (model universe)
50% data coverage
ℹ️
Risk Rating
17
Low
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on 0RQD to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

What is Essity AB Series B?

Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally.

0RQD · Verdict

Moderate reward · low risk

0RQD stands out on cash flow and volatility, but watch the profitability signal.

Based on 75% data coverage

0RQD · Verdict

What’s working & what to watch

Strengths 3

  • Cash flow95/100

    Top decile vs peers

  • Volatility80/100

    Top decile vs peers

  • Balance sheet75/100

    Current ratio 1.13

Watchouts 1

  • Profitability33/100

    15% return on equity

Model-based scoring. For information only — not financial advice.

What is Essity AB Series B?

Essity AB (publ) develops, produces, and sells hygiene and health products and services in Europe, North and Latin America, Asia, and internationally. The company operates through three segments: Health & Medical, Consumer Goods, and Professional Hygiene. The company is listed on the LSE in UK, with a market capitalisation of 183.28B.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Thin or inconsistent margins weigh on earnings quality.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation is less clear with a negative earnings base.

OpenBook Logo Analysis

Reward: Moderate (48)

The scoring profile indicates limited reward potential at this time, with valuation and growth offering the most support. Risk indicators are low, suggesting a relatively contained downside profile.

For informational purposes only. Not financial advice.

Company Information
SectorN/A
Market Cap183.28B
P/E RatioN/A
Dividend Yield3.48%
52 Week High282.7503
52 Week Low228.3623
Last AnnualDecember
IPO DateN/A
IncorporatedUK
Shares OutstandingN/A
No. of Employees36,000
IndustryN/A
ExchangeLSE
Beta0.375
CurrencySEK